Sign Up to like & get
recommendations!
1
Published in 2022 at "Andrology"
DOI: 10.1111/andr.13304
Abstract: INTRODUCTION Erectile dysfunction (ED) is associated with diabetes mellitus with an estimated prevalence of 52.5% in the diabetic population. The first-line therapy for ED are phosphodiesterase type 5 inhibitors (PDE5i), but data suggests that diabetic…
read more here.
Keywords:
testosterone recovery;
diabetic men;
therapy;
recovery therapy ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "International Journal of Urology"
DOI: 10.1111/iju.15098
Abstract: Due to the fear generated by COVID‐19 in Spring 2020, many patients postponed their scheduled outpatient visits. To differentiate those patients with prostate cancer (PCa) whose androgen deprivation therapy (ADT) injection treatment can be postponed,…
read more here.
Keywords:
testosterone recovery;
prostate cancer;
therapy;
androgen deprivation ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "JCO Clinical Cancer Informatics"
DOI: 10.1200/cci.22.00010
Abstract: PURPOSE Data quality and standardization remain a challenge when analyzing real-world clinical data. We built a clinical research database, using machine learning and natural learning processing, and investigated factors influencing testosterone recovery (T-recovery) in patients…
read more here.
Keywords:
information;
testosterone recovery;
prostate cancer;
recovery patients ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2020 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2020.38.6_suppl.188
Abstract: 188Background: Androgen deprivation therapy (ADT) can cause considerable toxicity and may influence outcome. The study assessed the impact of testosterone recovery (TR) on survival after ADT and de...
read more here.
Keywords:
survival;
recovery biomarker;
testosterone recovery;
cause ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2024 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2024.42.4_suppl.174
Abstract: 174 Background: Nearly all men with metastatic hormone-sensitive prostate cancer who receive intermittent androgen deprivation therapy (ADT) will experience a relapse within six months of testosterone recovery. We hypothesized that intensifying intermittent ADT with dual…
read more here.
Keywords:
testosterone recovery;
prostate;
six months;
sbrt ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2025 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2025.43.16_suppl.e17113
Abstract: e17113 Background: The use of PSMA PET/CT is better established for the staging of high-risk localized and biochemical recurrent prostate cancer; however no clinical trial assessed the importance of PSMA PET/CT in the mHSPC scenario,…
read more here.
Keywords:
cohort;
psma pet;
treatment;
testosterone recovery ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2018 at "Investigative and Clinical Urology"
DOI: 10.4111/icu.2018.59.1.18
Abstract: Purpose We investigated factors affecting testosterone recovery after androgen deprivation therapy (ADT) withdrawal in patients with prostate cancer. Materials and Methods The medical records of patients who underwent radical prostatectomy with ADT were retrospectively reviewed.…
read more here.
Keywords:
recovery;
recovery androgen;
testosterone recovery;
adt ... See more keywords